« Back to Record
Citation APA

Vermorken, J. B., Remenar, E., van Herpen, C. M. L., Gorlia, T., Mesia, R., Degardin, M., Stewart, J., Jelic, S., Betka, J., Preiss, J. H., Van Den Weyngaert, D., Awada, A., Cupissol, D., Kienzer, H. R., Rey, A., Desaunois, I., Bernier, J., Lefebvre, J.-L., & EORTC 24971/TAX 323 Study Group, (2007). Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England journal of medicine, 357(17), 1695-1704. doi:10.1056/NEJMoa071028


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53575

Vermorken, J. B., Remenar, E., van Herpen, C. M. L., Gorlia, T., Mesia, R., Degardin, M., Stewart, J., Jelic, S., Betka, J., Preiss, J. H., Van Den Weyngaert, D., Awada, A., Cupissol, D., Kienzer, H. R., Rey, A., Desaunois, I., Bernier, J., Lefebvre, J.-L., & EORTC 24971/TAX 323 Study Group, (2007). Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England journal of medicine, 357(17), 1695-1704. doi:10.1056/NEJMoa071028